Literature DB >> 18171086

Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity.

Katie French1, Justin J Yerbury, Mark R Wilson.   

Abstract

Alpha2-macroglobulin (alpha2M) is a major human blood glycoprotein best known for its ability to inhibit a broad spectrum of proteases by a unique trapping method. This action induces an "activated" conformation of alpha2M with an exposed binding site for the low-density lipoprotein receptor, facilitating clearance of alpha2M/protease complexes from the body. This report establishes that protease activation also modulates a potent chaperone-like action of alpha2M that has broad specificity for proteins partly unfolded as a result of heat or oxidative stress. Protease-mediated activation of alpha2M abolishes its chaperone-like activity. However, native alpha2M is able to form soluble complexes with stressed proteins and then subsequently become activated by interacting with a protease, providing a potential mechanism for the in vivo clearance of alpha2M/stressed protein/protease complexes. We propose that alpha2M is a newly discovered and unique member of a small group of abundant extracellular proteins with chaperone properties that patrol extracellular spaces for unfolded/misfolded proteins and facilitate their disposal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171086     DOI: 10.1021/bi701976f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands.

Authors:  Thomas E Finn; Andrea C Nunez; Margaret Sunde; Simon B Easterbrook-Smith
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

2.  BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.

Authors:  Hanna Willander; Jenny Presto; Glareh Askarieh; Henrik Biverstål; Birgitta Frohm; Stefan D Knight; Jan Johansson; Sara Linse
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

3.  Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.

Authors:  V R Varma; S Varma; Y An; T J Hohman; S Seddighi; R Casanova; A Beri; E B Dammer; N T Seyfried; O Pletnikova; A Moghekar; M R Wilson; J J Lah; R J O'Brien; A I Levey; J C Troncoso; M S Albert; M Thambisetty
Journal:  Mol Psychiatry       Date:  2016-11-22       Impact factor: 15.992

4.  α2-macroglobulin in Alzheimer's disease: new roles for an old chaperone.

Authors:  Sahba Seddighi; Vijay Varma; Madhav Thambisetty
Journal:  Biomark Med       Date:  2018-03-14       Impact factor: 2.851

5.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

6.  Hypochlorite-induced structural modifications enhance the chaperone activity of human α2-macroglobulin.

Authors:  Amy R Wyatt; Janet R Kumita; Richard W Mifsud; Cherrie A Gooden; Mark R Wilson; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

7.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

8.  Inhibition of beta2-microglobulin amyloid fibril formation by alpha2-macroglobulin.

Authors:  Daisaku Ozawa; Kazuhiro Hasegawa; Young-Ho Lee; Kazumasa Sakurai; Kotaro Yanagi; Tadakazu Ookoshi; Yuji Goto; Hironobu Naiki
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

9.  Structural characterization of clusterin-chaperone client protein complexes.

Authors:  Amy R Wyatt; Justin J Yerbury; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

10.  Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptake.

Authors:  Justin J Yerbury; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2009-05-27       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.